Infectious Disease Control
RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine
GERMANTOWN, Md. and GUANGZHOU, China, April 28, 2023 /PRNewswire/ -- RNAimmune, Inc.(the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, today announced that the Company has received a clearance from the Uni...
2023-04-28 00:29
2749
Bioved Pharmaceuticals granted a US Patent for its oral, natural plant-based product, Artovid-20® for the treatment of Covid-19
SAN JOSE, Calif., April 26, 2023 /PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets for Covid-19. The Patent titled "Methods and Compounds for Treating Effects of Covid-19 Disease," grants 2...
2023-04-26 03:00
1649
Bugworks Research Inc. to Present Eight Posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, in Copenhagen, Denmark
BANGALORE, India and DELAWARE CITY, Del. and ADELAIDE, Australia, April 17, 2023 /PRNewswire/ -- Bugworks Research Inc., a clinical-stage biopharmaceutical company, is set to present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd European...
2023-04-17 07:00
2110
Tianlong Announces Global Release of GeneFlex Nucleic Acid Extractor and Gentier mini+ Real-time PCR System
Featuring flexibility and portability, the two products are ideal for small
laboratories or on-site testing needs.
XI'AN, China, March 31, 2023 /PRNewswire/ -- Tianlong
2023-03-31 20:04
3086
Seegene declares to share Syndromic PCR technologies to prevent future pandemics
* Localization of Seegene Syndromic PCR technologies with global partners for versatile and proactive response to local emerging healthcare demands. * Formation of a collaborative global network to aggressively develop innovative syndromic PCR assays, challenging boundaries of PCR application....
2023-03-28 19:00
1616
CGTN: How China keeps its promise to build a community of common health for mankind
BEIJING, March 27, 2023 /PRNewswire/ -- Recognizing China for its support during the pandemic, the Senate of theDominican Republic recently presented China with an award. The Senate's Vice President Santiago Zorrilla said at the award ceremony that theDominican Republic will always remember China...
2023-03-27 21:43
2018
CGTN: How China continues optimizing its COVID-19 response amid other outbreaks
BEIJING, March 24, 2023 /PRNewswire/ -- China has entered a new phase of epidemic prevention and control after it downgraded the management of COVID-19 response into Class B infectious diseases. "The overall situation of epidemic response is good nationwide," according to a meeting held by the St...
2023-03-24 18:33
2523
World TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa
Transformative Next Generation Sequencing (NGS) Innovation expands access to genomic testing and enables personalized medicine for patients with Tuberculosis (TB) CAPE TOWN, South Africa, March 24, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-bas...
2023-03-24 16:07
1625
Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results
Company maintains priority focus on clinical programs to develop a novel f unctional cure for hepatitis B viral (HBV) infection and a potential first-of-its-kind treatment for postpartum depression (PPD) and major depressive disorders (MDD) Multiple Phase 2a proof-of-concept (POC) clinical data r...
2023-03-24 13:33
3472
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
SEOUL, South Korea, March 23, 2023 /PRNewswire/ -- CodeSteri, a leading provider of disinfection solutions, is proud to announce the launch of PlaClin-M, a revolutionary device designed to help ensure a clean and safe environment in offices, commercial establishments, and public spaces. CodeSteri...
2023-03-23 13:00
2132
Two-Component Recombinant COVID-19 Vaccine ReCOV Granted With Emergency Use Authorization In Mongolia
TAIZHOU, China, March 21, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that in accordance with the Mongolian law on the prevention of novel coronavirus (SARS-CoV-2) outbreak, the Company was granted an...
2023-03-21 13:59
2493
IVI launches global study to determine the burden of HPV among girls and women
SEOUL, South Korea, March 8, 2023 /PRNewswire/ -- The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announced the start of a multi-country study to better understand...
2023-03-08 16:40
1706
Foreign national arrested on suspicion of illegally importing livestock products into Japan using international mail
YOKOHAMA, Japan, Feb. 21, 2023 /PRNewswire/ -- On January 25, 2023, a foreign national was arrested on suspicion of illegally importing livestock products intoJapan using international mail. Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9...
2023-02-21 08:00
2235
Significant Progress Made on the Trivalent Recombinant Protein COVID-19 Vaccine against Subvariants including XBB.1.5 and BA.5 by WestVac Biopharma
CHENGDU, China, Feb. 20, 2023 /PRNewswire/ -- Recently, with the support of the National Key R&D Program ofChina, following the clinical trial approval for Recombinant Variant COVID-19 Vaccine (Sf9 cell) approved by NMPA, WestVac Biopharma (Guangzhou) Co., Ltd. (hereinafter referred to as "WestVa...
2023-02-20 12:43
3139
CGTN: China achieves 'major, decisive' victory in COVID-19 response: CPC leadership
BEIJING, Feb. 17, 2023 /PRNewswire/ -- Over the past three years, China has always been putting people's lives and health first and adapting its COVID-19 response in light of the evolving situation, in efforts widely believed to have bought precious time for a smooth transition. The country has ...
2023-02-17 15:27
3052
Immuno Cure kick off Phase I Clinical Trial in Shenzhen
A significant step for developing our PD-1-Enhanced DNA Vaccine against HIV/AIDS HONG KONG, Feb. 16, 2023 /PRNewswire/ -- Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in PD-1-Enhanced DNA vaccines and immunotherapies,announced the ...
2023-02-16 20:36
4553
Tetracore Announces USDA Purchase of ASF and FMD Diagnostic Test Kits
ROCKVILLE, Md., Feb. 16, 2023 /PRNewswire/ -- Tetracore, Inc. (Tetracore®) is pleased to announce its partnership with the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) to provide a stock of PCR kits for both African Swine Fever (ASF) and Foo...
2023-02-16 04:35
2725
U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine
* Modified agreement also includes the development of an updated vaccine in fall 2023 GAITHERSBURG, Md., Feb. 13, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, toda...
2023-02-13 21:00
2713
U.S. Centers for Disease Control to extend National Wastewater Surveillance System contract with Biobot Analytics
CAMBRIDGE, Mass., Feb. 9, 2023 /PRNewswire/ -- The U.S. Centers for Disease Control and Prevention (CDC) has extended its partnership with Biobot Analytics through the National Wastewater Surveillance System (NWSS) to bring COVID-19 and mpox (formerly monkeypox) wastewater analysis to communities...
2023-02-09 06:15
2270
Pierre Fabre pursues its commitment against rare diseases in the pediatric, oncology and dermatology fields.
RARE DISEASE DAY – February 28th, 2023 The diseases are rare, but they impact a lot of people : nearly 300 million people are affected worldwide1. CASTRES, France, Feb. 6, 2023 /PRNewswire/ -- International Rare Disease Day® will be held onFebruary 28, an opportunity for the Pierre Fabre Group t...
2023-02-06 18:00
1857
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 272 media titles]
2024-04-24 17:09
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9195
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7769
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
4889
